
    
      This is a prospective cohort study with two groups: survivors of acute lymphoblastic leukemia
      (ALL) who have recently completed therapy (cases) and healthy siblings (controls) frequency
      matched by age and sex. Subjects in each group will have two visits. For cases, the first
      visit will be approximately 6 months after completion of treatment for ALL; for their
      siblings, the first visit occur at approximately the same time. For both cases and controls,
      the second visit will be 2 to 2.5 years after the first visit.
    
  